XML 23 R2.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Assets    
Cash and due from banks $ 312,396 $ 251,541
Interest bearing deposits with banks 185,841 177,088
Investment securities:    
Held to maturity (fair value of $2,121,203 at September 30, 2019 and $2,034,943 at December 31, 2018) 2,093,757 2,068,246
Available for sale 1,628,062 1,749,544
Total investment securities 3,721,819 3,817,790
Loans held for sale, at fair value 41,621 35,155
Loans 26,567,159 25,035,469
Less: Allowance for loan losses (161,853) (151,859)
Net loans 26,405,306 24,883,610
Premises and equipment, net 309,730 341,630
Lease right of use assets 286,960  
Bank owned life insurance 440,026 439,602
Accrued interest receivable 97,282 95,296
Goodwill 1,084,665 1,084,665
Other intangible assets, net 68,150 76,990
Other assets 811,743 659,721
Total Assets 33,765,539 31,863,088
Deposits:    
Non-interest bearing 6,379,271 6,175,495
Interest bearing:    
Savings, NOW and money market 11,294,679 11,213,495
Time 7,872,172 7,063,984
Total deposits 25,546,122 24,452,974
Short-term borrowings 1,825,417 2,118,914
Long-term borrowings 2,250,633 1,654,268
Junior subordinated debentures issued to capital trusts 55,631 55,370
Lease liabilities 311,145 3,125
Accrued expenses and other liabilities 218,516 227,983
Total Liabilities 30,207,464 28,512,634
Shareholders’ Equity    
Common stock (no par value, authorized 450,000,000 shares; issued 332,101,525 shares at September 30, 2019 and 331,634,951 shares at December 31, 2018) 116,650 116,240
Surplus 2,807,266 2,796,499
Retained earnings 454,020 299,642
Accumulated other comprehensive loss (26,468) (69,431)
Treasury stock, at cost (295,961 common shares at September 30, 2019 and 203,734 common shares at December 31, 2018) (3,084) (2,187)
Total Shareholders’ Equity 3,558,075 3,350,454
Total Liabilities and Shareholders’ Equity 33,765,539 31,863,088
Series A    
Shareholders’ Equity    
Preferred stock, no par value; authorized 50,000,000 shares 111,590 111,590
Series B    
Shareholders’ Equity    
Preferred stock, no par value; authorized 50,000,000 shares $ 98,101 $ 98,101